Vigil Neuroscience, Inc. (VIGL)
NASDAQ: VIGL · IEX Real-Time Price · USD
4.005
-0.365 (-8.35%)
At close: Jul 2, 2024, 4:00 PM
3.970
-0.035 (-0.87%)
After-hours: Jul 2, 2024, 7:06 PM EDT
Vigil Neuroscience Market Cap
Vigil Neuroscience has a market cap or net worth of $150.53 million as of July 2, 2024. Its market cap has decreased by -56.06% in one year.
Market Cap
150.53M
Enterprise Value
61.58M
1-Year Change
-56.06%
Ranking
Category
Stock Price
$4.01
Market Cap Chart
Since the IPO on January 7, 2022, Vigil Neuroscience's market cap has decreased from $395.70M to $150.53M, a decrease of -61.96%. That is a compound annual growth rate of -32.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 164.20M | 35.37% |
| Dec 29, 2023 | 121.30M | -72.73% |
| Dec 30, 2022 | 444.80M | 12.41% |
| Jan 7, 2022 | 395.70M | - |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaxart | 151.76M |
| OptiNose | 150.63M |
| Compugen | 150.41M |
| Stereotaxis | 150.41M |
| Context Therapeutics | 150.37M |
| TruBridge | 150.07M |
| TriSalus Life Sciences | 149.92M |
| Atossa Therapeutics | 149.65M |